Login / Signup

Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda.

M HaridasVijith SasidharPrajeesh NathJ AbhithajA SabuP Rammanohar
Published in: Future journal of pharmaceutical sciences (2021)
In silico studies suggest that the phytochemical compounds in C. medica and Z. officinale may have good potential in reducing viral load and shedding of SARS-CoV-2 in the nasal passages. Further studies are recommended to test its efficacy in humans for mitigating the transmission of COVID-19.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • molecular docking
  • case control
  • risk assessment